ARTERIOGENESIS DAN ANGIOGENESIS PADA STROKE HEMORAGIK:MEMPERTAJAM KONSEP UNTUK MEMPEROLEH MANFAAT TERBAIK NEOVASKULARISASI *
DOI:
https://doi.org/10.21776/ub.jkb.2008.024.01.6Abstract
Arteriogenesis and angiogenesis contribute both to  the damage and repair in hemorrhagic stroke. Understanding and unraveling the fundamental and mechanisms of these processes should facilitate the development of treatment strategies to improve outcome after stroke. This article describes briefly the basic principles of arteriogenesis and angiogenesis completed with some key molecular players, followed by aperspective of the author on how to use those neovascularization to benefit repair and recovery processes in post-hemorrhagic stroke. Key Words : arteriogenesis, angiogenesis, hemorrhagic, strokeDownloads
References
RSSA. Laporan Tahunan RS dr. Saiful Anwar Malang. 2006
Gijn, J.v., Kerr, R.S. & Rinkel, G.J.E. Subarachnoid haemorrhage. Lancet, 2007; 369: 306-318.
Xi, G., Keep, R.F. & Hoff, J.T. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol5;2006; 53-63.
Mendelow, A.D. et al. Early surgery versus initial conservative treatmentin patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial.The Lancet, 2005; 365:387-397.
Dennis, M.S. Outcome after brain hemorrhage. Cerebrovascular Disease 2003;16(1): 9-13.
Somes, J. & Bergman, D.L. ABCDs of Acute Stroke Intervention. J Emerg Nurs 2007; 33: 228-34.
Yamada, Y. et al. Genetic Risk for Ischemic and Hemorrhagic Stroke. Arterioscler Thromb Vasc Biol, 2006; 26:1920-1925.
Lu, A. et al. Brain genomics of intracerebral hemorrhage. Journal of Cerebral Blood Flow & Metabolism; 2006; 26:230-252.
Liu, X.S. et al. Stroke induces gene profile changes associated withneurogenesis and angiogenesis in adult subventricular zone progenitor cells.J Cereb Blood Flow Metab, 2006; 27: 564-574.
Sutherland, G.R. & Auer, R.N. Primary intracerebral hemorrhage. Journal of Clinical Neuroscience, 2006;13: 511-517.
Grundmann, S., Piek, J.J., Pasterkamp, G. & Hoefer, I.E. Arteriogenesis: basic mechanisms and therapeutic stimulation. European Journal of Clinical Investigation, 2007;37: 755-766.
Carmeliet, P. Angiogenesis in health and disease. Nature Medicine,2003; 9: 653-66.
Jain, R.K. Molecular regulation of vessel maturation. Nature medicine, 2003; 9, 685-693.
Royen, N.v. et al. START Trial A Pilot Study on STimulation of ARTeriogenesis Using Subcutaneous Application of Granulocyte-Macrophage Colony-Stimulating Factor as a New Treatment for Peripheral Vascular Disease. Circulation, 2005; 112: 1040-1046.
Burri, P.H., Hlushchuk, R. & Djonov, V. Intussusceptive angiogenesis: Its emergence, its characteristics, and its significance. Developmental Dynamics, 2004; 231:474-488.
Adams, R.H. & Alitalo, K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol, 2007; 8: 464-478.
Heil, M., Wagner, S. & Schaper, W.Arterial regeneration by collateral artery growth (arteriogenesis).Drug Discovery Today: Disease Models, 2004; 1: 265-271.
Carmeliet, P. Angiogenesis in life, disease and medicine. Nature, 2005; 438: 932-936.
Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. Nature Medicine, 2000; 6:389-395.
Hellstrom, M. et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature, 2007; 445: 776-780.
Semenza, G.L. Vasculogenesis, Angiogenesis, and Arteriogenesis: Mechanisms of Blood Vessel Formation and Remodeling. Journal of Cellular Biochemistry, 2007; 102: 840-847.
Mazure, N.M., Brahimi-Horn, M.C. & Pouysségur,J. Protein kinases and the hypoxia-inducible factor-1,two switches in angiogenesis. Current Pharmaceutical Design, 2003; 9: 531-541.
Kamei, M. et al. Endothelial tubes assemble from intracellular vacuoles in vivo. Nature, 2006; 442:453-456 (2006).
Red-Horse, K., Crawford, Y., Shojaei, F. & Ferrara, N. Endothelium-Microenvironment Interactions in the Developing Embryo and in the Adult. Developmental Cell, 2007;12:181-194.
Taguchi, A. et al. Administration of CD34+ cells after stroke enhancesneurogenesis via angiogenesisin a mouse model.The Journal of Clinical Investigation, 2004; 114: 330-338.
Pendlebury, S.T. & Rothwell, P.M. Management of stroke. The Foundation Years, 2006; 2:199-206.
Tang, T. et al. Cerebral angiogenesis after collagenase-induced intracerebral hemorrhage in rats. Brain Research, 2007; 1175: 134-142.
Yu, S.W., Friedman, B., Cheng, Q. & Lyden, P.D. Stroke-evoked angiogenesis results in a transient population of microvessels. Journal of Cerebral Blood Flow & Metabolism, 2007; 27: 755-763.
Manoonkitiwongsa, P.S., Jackson-Friedman, C., McMillan, P.J., Schultz, R.L. & Lyden, P.D. Angiogenesis After Stroke Is Correlated With Increased Numbers of Macrophages: The Clean-up Hypothesis. Journal of Cerebral Blood Flow and Metabolism, 2001: 21:1223-1231.
Thurston, G. et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nature Medicine, 2000; 6:460-463.
Grossetete, M. & Rosenberg, G.A. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse. Journal of Cerebral Blood Flow & Metabolism,2007:1-12.
Gu, Z. et al. A Highly Specific Inhibitor of Matrix Metalloproteinase-9 Rescues Laminin from Proteolysis and Neurons from Apoptosis in Transient Focal Cerebral Ischemia.The Journal of Neuroscience, 2005; 25: 6401- 6408.
Rosell, A. et al. Increased Brain Expression of Matrix Metalloproteinase-9 After Ischemic and Hemorrhagic Human Stroke. Stroke, 2006; 37:1399-1406.
Zhao, B.-Q. et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med, 2006;12: 441-445.
Lee, C.Z., Xue, Z., Zhu, Y., Yang, G.-Y. & Young, W.L. Matrix Metalloproteinase-9 Inhibition Attenuates Vascular Endothelial Growth Factor-Induced Intracerebral Hemorrhage. Stroke, 2007; 38: 2563-2568.
Lee, S.-R., Tsuji, K., Lee, S.-R. & Lo, E.H. Role of Matrix Metalloproteinases in Delayed Neuronal Damage after Transient Global Cerebral Ischemia. J. Neurosci, 2004; 24: 671-678.
Lee, S.-T. et al. Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement. J Cereb Blood Flow Metab, 2006: 26:536-544.
Zhao, B.-Q., Tejima, E. & Lo, E.H. Neurovascular Proteases in Brain Injury, Hemorrhageand Remodeling After Stroke.Stroke, 2007; 38: 748-752.
Wang, J. & Tsirka, S.E. Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain, 2005;128:1622-1633 (2005).
Yong, V.W., Power, C., Forsyth, P. & Edwards, D.R. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci, 2001; 2: 502-511.
Yong, V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci, 2005; 6: 931-944.
Calabrese, V. et al. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci, 2007; 8: 766-775 (2007).
Xue, M., Hollenberg, M.D. & Wee Yong, V. Combination of Thrombin and Matrix Metalloproteinase-9 Exacerbates Neurotoxicity in Cell Culture and Intracerebral Hemorrhage in Mice. J. Neurosci, 2006; 26: 10281-10291.
Vailhé, B. & Feige, J.-J. Thrombospondins as Anti-Angiogenic Therapeutic Agents. Current Pharmaceutical Design, 2003; 9: 583-588.
Dor, Y. et al. Conditional switching of VEGF provides new insightsinto adult neovascularization and pro-angiogenic therapy. The EMBO Journal, 2002; 21:1939-1947.
Dor, Y., Djonov, V. & Keshet, E.L.I. Induction of Vascular Networks in Adult Organs: Implications to Proangiogenic Therapy. Ann NY Acad Sci, 2003; 995: 208-216 (2003).
Dirnagl, U. Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab, 2006; 26: 1465-1478.
Jain, R.K., Finn, A.V., Kolodgie, F.D., Gold, H.K. & Virmani, R. Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization. Nature Clinical Practice Cardiovascular Medicine, 2007; 4: 491-502.
Hoefer, I.E., Piek, J.J. & Pasterkamp, G. Pharmaceutical interventions to influence arteriogenesis: new concepts to treat ischemic heart disease. Current Medicinal Chemistry, 2006;13: 979-987.
Tejima, E. et al. Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage. Journal of Cerebral Blood Flow & Metabolism, 2007; 27: 460-468.
Yong, V., Agrawal, S. & Stirling, D. Targeting MMPs in Acute and Chronic Neurological Conditions. Neurotherapeutics, 2007; 4: 580-589.
Carmeliet, P. Blood vessels and nerves: common signals, pathways and diseases. Nature Reviews Genetics, 2003; 4: 710-720.
Chopp, M., Zhang, Z.G. & Jiang, Q. Neurogenesis, Angiogenesis, and MRI Indices of Functional Recovery From Stroke. Stroke, 2007; 38: 827-831.
Teng, H. et al. Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab, 2007.
Chopp, M., Li, Y. & Zhang, J. Plasticity and remodeling of brain. Journal of the Neurological Sciences, 2008; 265: 97-101.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
